These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29607865)

  • 1. The relationship of erythropoietin receptor expression and prognosis in glioblastoma multiforme patients.
    Cevik S; Kitis S; Evran S; Akkaya E; Tosuner Z; Hanimoglu H
    Niger J Clin Pract; 2018 Apr; 21(4):502-506. PubMed ID: 29607865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of erythropoietin and erythropoietin receptor in gastric adenocarcinoma.
    Wang L; Li HG; Xia ZS; Wen JM; Lv J
    World J Gastroenterol; 2011 Sep; 17(34):3933-40. PubMed ID: 22025882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology.
    Torregrossa F; Aguennouz M; La Torre D; Sfacteria A; Grasso G
    World Neurosurg; 2019 Nov; 131():346-355. PubMed ID: 31658577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of serum levels and tissue expression of two genes IGFBP-2 and IGFBP-3 act as potential biomarker for predicting the progression and survival in patients with glioblastoma multiforme.
    Abdolhoseinpour H; Mehrabi F; Shahraki K; Khoshnood RJ; Masoumi B; Yahaghi E; Goudarzi PK
    J Neurol Sci; 2016 Jul; 366():202-206. PubMed ID: 27288807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
    Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
    Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma multiforme cells: expression of erythropoietin receptor and response to erythropoietin.
    Yin D; Kawabata H; Tcherniamtchouk O; Huynh T; Black KL; Koeffler HP
    Int J Oncol; 2007 Nov; 31(5):1193-8. PubMed ID: 17912447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial spin-labeling perfusion MRI stratifies progression-free survival and correlates with epidermal growth factor receptor status in glioblastoma.
    Qiao XJ; Ellingson BM; Kim HJ; Wang DJ; Salamon N; Linetsky M; Sepahdari AR; Jiang B; Tian JJ; Esswein SR; Cloughesy TF; Lai A; Nghiemphu L; Pope WB
    AJNR Am J Neuroradiol; 2015 Apr; 36(4):672-7. PubMed ID: 25542879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of erythropoietin and erythropoietin receptor in cervical cancer and relationship to survival, hypoxia, and apoptosis.
    Leo C; Horn LC; Rauscher C; Hentschel B; Liebmann A; Hildebrandt G; Höckel M
    Clin Cancer Res; 2006 Dec; 12(23):6894-900. PubMed ID: 17145806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
    Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
    Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor is related to poor survival in glioblastomas: single-institution experience.
    Choi Y; Song YJ; Lee HS; Hur WJ; Sung KH; Kim KU; Choi SS; Kim SJ; Kim DC
    Yonsei Med J; 2013 Jan; 54(1):101-7. PubMed ID: 23225805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme.
    Kuijlen JM; Mooij JJ; Platteel I; Hoving EW; van der Graaf WT; Span MM; Hollema H; den Dunnen WF
    J Neurooncol; 2006 Jun; 78(2):161-71. PubMed ID: 16544055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Met expression is associated with time to recurrence in patients with glioblastoma multiforme.
    Liu W; Fu Y; Xu S; Ding F; Zhao G; Zhang K; Du C; Pang B; Pang Q
    J Clin Neurosci; 2011 Jan; 18(1):119-21. PubMed ID: 20832323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Nestin and EGFR in Patients with Glioblastoma Multiforme in a Public Hospital in Iran.
    Matini AH; Mofidi Naeini M; Haddad Kashani H; Vakili Z
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):2889-2894. PubMed ID: 33112545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.
    Simmons ML; Lamborn KR; Takahashi M; Chen P; Israel MA; Berger MS; Godfrey T; Nigro J; Prados M; Chang S; Barker FG; Aldape K
    Cancer Res; 2001 Feb; 61(3):1122-8. PubMed ID: 11221842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysialic acid neural cell adhesion molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines.
    Amoureux MC; Coulibaly B; Chinot O; Loundou A; Metellus P; Rougon G; Figarella-Branger D
    BMC Cancer; 2010 Mar; 10():91. PubMed ID: 20219118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and invasiveness of astrocytomas promoted by erythropoietin.
    Mohyeldin A; Dalgard CL; Lu H; Mcfate T; Tait AS; Patel VC; Wong K; Rushing E; Roy S; Acs G; Verma A
    J Neurosurg; 2007 Feb; 106(2):338-50. PubMed ID: 17410721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival.
    Herzog S; Fink MA; Weitmann K; Friedel C; Hadlich S; Langner S; Kindermann K; Holm T; Böhm A; Eskilsson E; Miletic H; Hildner M; Fritsch M; Vogelgesang S; Havemann C; Ritter CA; Meyer zu Schwabedissen HE; Rauch B; Hoffmann W; Kroemer HK; Schroeder H; Bien-Möller S
    Neuro Oncol; 2015 Feb; 17(2):223-42. PubMed ID: 25155357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis.
    Yang Z; Sun B; Zhao X; Shao B; An J; Gu Q; Wang Y; Dong X; Zhang Y; Qiu Z
    Int J Clin Exp Pathol; 2015; 8(4):4033-43. PubMed ID: 26097591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway.
    Cheng P; Ma Y; Gao Z; Duan L
    Med Sci Monit; 2018 Dec; 24():8916-8924. PubMed ID: 30531692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinicopathological and molecular analysis of glioblastoma multiforme with long-term survival.
    Das P; Puri T; Jha P; Pathak P; Joshi N; Suri V; Sharma MC; Sharma BS; Mahapatra AK; Suri A; Sarkar C
    J Clin Neurosci; 2011 Jan; 18(1):66-70. PubMed ID: 20888234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.